Toll-like receptors and cancer (original) (raw)

• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001).
  Article CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749–759 (2005).
  Article CAS Google Scholar
• Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003).
  Article CAS PubMed Google Scholar
• Lee, M. S. & Kim, Y. J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447–480 (2007).
  Article CAS PubMed Google Scholar
• Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (Pt 1), 1–13 (1989).
  Article CAS PubMed Google Scholar
• Ohashi, K., Burkart, V., Flohe, S. & Kolb, H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164, 558–561 (2000).
  Article CAS PubMed Google Scholar
• Vabulas, R. M. et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276, 31332–31339 (2001).
  Article CAS PubMed Google Scholar
• Vabulas, R. M. et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277, 15107–15112 (2002).
  Article CAS PubMed Google Scholar
• Asea, A. et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028–15034 (2002).
  Article CAS PubMed Google Scholar
• Dybdahl, B. et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 105, 685–690 (2002).
  Article CAS PubMed Google Scholar
• Vabulas, R. M. et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277, 20847–20853 (2002).
  Article CAS PubMed Google Scholar
• Roelofs, M. F. et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J. Immunol. 176, 7021–7027 (2006).
  Article CAS PubMed Google Scholar
• Park, J. S. et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290, C917–924 (2006).
  Article CAS PubMed Google Scholar
• Park, J. S. et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370–7377 (2004).
  Article CAS PubMed Google Scholar
• Liu-Bryan, R., Scott, P., Sydlaske, A., Rose, D. M. & Terkeltaub, R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52, 2936–2946 (2005).
  Article CAS PubMed Google Scholar
• Liu-Bryan, R., Pritzker, K., Firestein, G. S. & Terkeltaub, R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J. Immunol. 174, 5016–5023 (2005).
  Article CAS PubMed Google Scholar
• Guillot, L. et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168, 5989–5992 (2002).
  Article CAS PubMed Google Scholar
• Okamura, Y. et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229–10233 (2001).
  Article CAS PubMed Google Scholar
• Johnson, G. B., Brunn, G. J., Kodaira, Y. & Platt, J. L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168, 5233–5239 (2002).
  Article CAS PubMed Google Scholar
• Schaefer, L. et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223–2233 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Smiley, S. T., King, J. A. & Hancock, W. W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167, 2887–2894 (2001).
  Article CAS PubMed Google Scholar
• Termeer, C. et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99–111 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Med. 11, 1173–1179 (2005).
  Article CAS PubMed Google Scholar
• Taylor, K. R. et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079–17084 (2004).
  Article CAS PubMed Google Scholar
• Taylor, K. R. et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265–18275 (2007).
  Article CAS PubMed Google Scholar
• Mukherjee, S., Vaishnava, S. & Hooper, L. V. Multi-layered regulation of intestinal antimicrobial defense. Cell. Mol. Life Sci. 65, 3019–3027 (2008).
  Article CAS PubMed Google Scholar
• Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Rev. Immunol. 3, 710–720 (2003).
  Article CAS Google Scholar
• Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R. P. & Pamer, E. G. MyD88-mediated signals induce the bactericidal lectin RegIII γ and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891–1900 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Blander, J. M. & Medzhitov, R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014–1018 (2004).
  Article CAS PubMed Google Scholar
• Nathan, C. & Shiloh, M. U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl Acad. Sci. USA 97, 8841–8848 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kleinert, H., Pautz, A., Linker, K. & Schwarz, P. M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255–266 (2004).
  Article CAS PubMed Google Scholar
• Park, H. S. et al. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173, 3589–3593 (2004).
  Article CAS PubMed Google Scholar
• Laroux, F. S., Romero, X., Wetzler, L., Engel, P. & Terhorst, C. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of Gram-negative bacteria. J. Immunol. 175, 5596–5600 (2005).
  Article CAS PubMed Google Scholar
• Remer, K. A., Brcic, M. & Jungi, T. W. Toll-like receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils. Immunol. Lett. 85, 75–80 (2003).
  Article CAS PubMed Google Scholar
• Picker, L. J. & Butcher, E. C. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10, 561–591 (1992).
  Article CAS PubMed Google Scholar
• Laudanna, C., Kim, J. Y., Constantin, G. & Butcher, E. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186, 37–46 (2002).
  Article CAS PubMed Google Scholar
• Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nature Immunol. 2, 947–950 (2001).
  Article CAS Google Scholar
• Sallusto, F. et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760–2769 (1998).
  Article CAS PubMed Google Scholar
• Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33 (1999).
  Article CAS PubMed Google Scholar
• Dieu, M. C. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373–386 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Gunn, M. D. et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189, 451–460 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nature Immunol. 5, 987–995 (2004).
  Article CAS Google Scholar
• Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).
  Article CAS PubMed Google Scholar
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  Article CAS PubMed Google Scholar
• Gerondakis, S., Grumont, R. J. & Banerjee, A. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 85, 471–475 (2007).
  Article CAS PubMed Google Scholar
• Reiner, S. L., Sallusto, F. & Lanzavecchia, A. Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 317, 622–625 (2007).
  Article CAS PubMed Google Scholar
• Martin, M., Katz, J., Vogel, S. N. & Michalek, S. M. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167, 5278–5285 (2001).
  Article CAS PubMed Google Scholar
• Martin, M., Rehani, K., Jope, R. S. & Michalek, S. M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunol. 6, 777–784 (2005).
  Article CAS Google Scholar
• Monick, M. M. et al. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J. Immunol. 166, 4713–4720 (2001).
  Article CAS PubMed Google Scholar
• Salaun, B., Romero, P. & Lebecque, S. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur. J. Immunol. 37, 3311–3318 (2007).
  Article CAS PubMed Google Scholar
• Aliprantis, A. O., Yang, R. B., Weiss, D. S., Godowski, P. & Zychlinsky, A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19, 3325–3336 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ruckdeschel, K. et al. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-β, but not MyD88, in bacteria-infected murine macrophages. J. Immunol. 173, 3320–3328 (2004).
  Article CAS PubMed Google Scholar
• Hsu, L. C. et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341–345 (2004).
  Article CAS PubMed Google Scholar
• De Trez, C. et al. TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-β, but not MyD88, regulate _Escherichia coli_-induced dendritic cell maturation and apoptosis in vivo. J. Immunol. 175, 839–846 (2005).
  Article CAS PubMed Google Scholar
• Smyth, M. J., Dunn, G. P. & Schreiber, R. D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 90, 1–50 (2006).
  Article CAS PubMed Google Scholar
• Larsen, P. H., Holm, T. H. & Owens, T. Toll-like receptors in brain development and homeostasis. Sci. STKE 2007, pe47 (2007).
  Article PubMed Google Scholar
• Michelsen, K. S. & Arditi, M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr. Opin. Hematol. 14, 48–54 (2007).
  Article CAS PubMed Google Scholar
• Fukata, M. et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862–877 (2006).
  Article CAS PubMed Google Scholar
• Brown, S. L. et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117, 258–269 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Rolls, A. et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nature Cell Biol. 9, 1081–1088 (2007).
  Article CAS PubMed Google Scholar
• Ma, Y. et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175, 209–215 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kigerl, K. A. et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102, 37–50 (2007).
  Article CAS PubMed Google Scholar
• Babcock, A. A. et al. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26, 12826–12837 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, D. et al. A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 282, 14975–14983 (2007).
  Article CAS PubMed Google Scholar
• Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241 (2004).
  Article CAS PubMed Google Scholar
• Cario, E., Gerken, G. & Podolsky, D. K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224–238 (2004).
  Article CAS PubMed Google Scholar
• Cario, E., Gerken, G. & Podolsky, D. K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359–1374 (2007).
  Article CAS PubMed Google Scholar
• Fukata, M. et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055–G1065 (2005).
  Article CAS PubMed Google Scholar
• Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I. & Stappenbeck, T. S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl Acad. Sci. USA 102, 99–104 (2005).
  Article CAS PubMed Google Scholar
• Araki, A. et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16–23 (2005).
  Article CAS PubMed Google Scholar
• Gibson, D. L. et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during _Citrobacter rodentium_-induced colitis. Cell. Microbiol (2007).
• Zhang, X. et al. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J. Immunol. 175, 4834–4838 (2005).
  Article CAS PubMed Google Scholar
• Seki, E. et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41, 443–450 (2005).
  Article CAS PubMed Google Scholar
• Campbell, J. S. et al. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J. Immunol. 176, 2522–2528 (2006).
  Article CAS PubMed Google Scholar
• Macedo, L. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am. J. Pathol. 171, 1774–1788 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Z. & Schluesener, H. J. Mammalian Toll-like receptors: from endogenous ligands to tissue regeneration. Cell. Mol. Life Sci. 63, 2901–2907 (2006).
  Article CAS PubMed Google Scholar
• Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nature Med. 13, 1324–1332 (2007).
  Article CAS PubMed Google Scholar
• Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Med. 13, 1050–1059 (2007).
  Article CAS PubMed Google Scholar
• Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191–195 (2002).
  Article CAS PubMed Google Scholar
• Jiang, D., Liang, J., Li, Y. & Noble, P. W. The role of Toll-like receptors in non-infectious lung injury. Cell Res. 16, 693–701 (2006).
  Article CAS PubMed Google Scholar
• Garay, R. P. et al. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. Eur. J. Pharmacol. 563, 1–17 (2007).
  Article CAS PubMed Google Scholar
• Coley, W. B. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin. Orthop. Relat. Res., 3–11 (1991).
• Okamoto, H., Shoin, S., Koshimura, S. & Shimizu, R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn. J. Microbiol. 11, 323–326 (1967).
  Article CAS PubMed Google Scholar
• Kikkawa, F. et al. Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma. Eur. J. Cancer 29A, 1542–1546 (1993).
  Article CAS PubMed Google Scholar
• Maehara, Y. et al. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am. J. Surg. 168, 36–40 (1994).
  Article CAS PubMed Google Scholar
• Sato, M. et al. Therapy for oral squamous cell carcinoma by tegafur and streptococcal agent OK-432 in combination with radiotherapy: association of the therapeutic effect with differentiation and apoptosis in the cancer cells. Apoptosis 2, 227–238 (1997).
  Article CAS PubMed Google Scholar
• Okamoto, M. et al. Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling. J. Immunother. (1997). 29, 78–86 (2006).
  Article Google Scholar
• Hironaka, K., Yamaguchi, Y., Okita, R., Okawaki, M. & Nagamine, I. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432. Anticancer Res. 26, 3701–3707 (2006).
  CAS PubMed Google Scholar
• Tsuji, S. et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 68, 6883–6890 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Uehori, J. et al. Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation. J. Immunol. 174, 7096–7103 (2005).
  Article CAS PubMed Google Scholar
• Razack, A. H. Bacillus Calmette-Guerin and bladder cancer. Asian J. Surg. 30, 302–309 (2007).
  Article PubMed Google Scholar
• Krieg, A. M. Development of TLR9 agonists for cancer therapy. J. Clin. Invest. 117, 1184–1194 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Otto, F. et al. Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur. J. Cancer 32A, 1712–1718 (1996).
  Article CAS PubMed Google Scholar
• Chicoine, M. R. et al. The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery 60, 372–380; discussion 381 (2007).
  Article PubMed Google Scholar
• Sfondrini, L. et al. Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J. Immunol. 176, 6624–6630 (2006).
  Article CAS PubMed Google Scholar
• Scheel, B. et al. Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. Eur. J. Immunol. 36, 2807–2816 (2006).
  Article CAS PubMed Google Scholar
• Stockfleth, E. et al. The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. Br. J. Dermatol. 149 (Suppl. 66), 53–56 (2003).
  Article CAS PubMed Google Scholar
• Spaner, D. E. & Masellis, A. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia 21, 53–60 (2007).
  Article CAS PubMed Google Scholar
• Carpentier, A. et al. Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma. Neuro Oncol. 8, 60–66 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Salaun, B., Coste, I., Rissoan, M. C., Lebecque, S. J. & Renno, T. TLR3 can directly trigger apoptosis in human cancer cells. J. Immunol. 176, 4894–4901 (2006).
  Article CAS PubMed Google Scholar
• El Andaloussi, A., Sonabend, A. M., Han, Y. & Lesniak, M. S. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia 54, 526–535 (2006).
  Article PubMed Google Scholar
• Haimovitz-Friedman, A. et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186, 1831–1841 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Nogueras, S. et al. Coupling of endothelial injury and repair. An analysis using an in vivo experimental model. Am. J. Physiol. Heart Circ. Physiol. 294, H708–H713 (2008).
  Article CAS PubMed Google Scholar
• Yusuf, N. Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res. 68, 615–622 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gaudreault, E., Fiola, S., Olivier, M. & Gosselin, J. Epstein–Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 81, 8016–8024 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Broering, R. et al. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J. Hepatol 48, 914–922 (2008).
  Article CAS PubMed Google Scholar
• Wu, J. et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46, 1769–1778 (2007).
  Article CAS PubMed Google Scholar
• Dolganiuc, A. et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127, 1513–1524 (2004).
  Article CAS PubMed Google Scholar
• Chang, S., Dolganiuc, A. & Szabo, G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 82, 479–487 (2007).
  Article CAS PubMed Google Scholar
• Yang, R. et al. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce α interferon and TH1 immune responses via MyD88. J. Virol. 78, 11152–11160 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrero, R. L. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol. 42, 879–885 (2005).
  Article CAS PubMed Google Scholar
• Uno, K. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1004–G1012 (2007).
  Article CAS PubMed Google Scholar
• Pidgeon, G. P. et al. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br. J. Cancer 81, 1311–1317 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Harmey, J. H. et al. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int. J. Cancer 101, 415–422 (2002).
  Article CAS PubMed Google Scholar
• Luo, J. L., Maeda, S., Hsu, L. C., Yagita, H. & Karin, M. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 6, 297–305 (2004).
  Article CAS PubMed Google Scholar
• Huang, B. et al. Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling. Cancer Res. 67, 4346–4352 (2007).
  Article CAS PubMed Google Scholar
• Jego, G., Bataille, R., Geffroy-Luseau, A., Descamps, G. & Pellat-Deceunynck, C. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia 20, 1130–1137 (2006).
  Article CAS PubMed Google Scholar
• Bohnhorst, J. et al. Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia 20, 1138–1144 (2006).
  Article CAS PubMed Google Scholar
• Huang, B. et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65, 5009–5014 (2005).
  Article CAS PubMed Google Scholar
• Maeda, S., Kamata, H., Luo, J. L., Leffert, H. & Karin, M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990 (2005).
  Article CAS PubMed Google Scholar
• Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007).
  Article CAS PubMed Google Scholar
• Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124–127 (2007).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS PubMed Google Scholar
• Oshima, M. et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803–809 (1996).
  Google Scholar
• Chulada, P. C. et al. Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 60, 4705–4708 (2000).
  CAS PubMed Google Scholar
• Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. & Matrisian, L. M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl Acad. Sci. USA 94, 1402–1407 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hong, K. H., Bonventre, J. C., O'Leary, E., Bonventre, J. V. & Lander, E. S. Deletion of cytosolic phospholipase A2 suppresses ApcMin-induced tumorigenesis. Proc. Natl Acad. Sci. USA 98, 3935–3939 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 652–656 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Rakoff-Nahoum, S., Hao, L. & Medzhitov, R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25, 319–329 (2006).
  Article CAS PubMed Google Scholar
• Okazaki, I. Role of AID in tumorigenesis. Adv. Immunol. 94, 245–273 (2007).
  Article CAS PubMed Google Scholar
• Xu, Z. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit. Rev. Immunol. 27, 367–397 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bucala, R. Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26, 281–285 (2007).
  Article CAS PubMed Google Scholar
• Phan, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635–639 (2004).
  Article CAS PubMed Google Scholar
• Li, M. et al. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128–7135 (2001).
  Article CAS PubMed Google Scholar
• Wang, J. H. Endotoxin/lipopolysaccharide activates NF-κB and enhances tumor cell adhesion and invasion through a β1 integrin-dependent mechanism. J. Immunol. 170, 795–804 (2003).
  Article CAS PubMed Google Scholar
• Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819–826 (2007).
  Article CAS PubMed Google Scholar
• Shchors, K. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev. 20, 2527–2538 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Coussens, L. M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382–1397 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Soucek, L. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Med. 13, 1211–1218 (2007).
  Article CAS PubMed Google Scholar
• Kitano, H. Cancer as a robust system: implications for anticancer therapy. Nature Rev. Cancer 4, 227–235 (2004).
  Article CAS Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
  Article CAS PubMed Google Scholar
• El-Omar, E. M., Ng, M. T. & Hold, G. L. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 27, 244–252 (2008).
  Article CAS PubMed Google Scholar
• Apetoh, L., Tesniere, A., Ghiringhelli, F., Kroemer, G. & Zitvogel, L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res. 68, 4026–4030 (2008).
  Article CAS PubMed Google Scholar
• Achyut, B. R., Ghoshal, U. C., Moorchung, N. & Mittal, B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum. Immunol. 68, 901–907 (2007).
  Article CAS PubMed Google Scholar
• He, J. F. et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 7, 194 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Zhou, X. X. et al. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol. Biomarkers Prev. 15, 862–866 (2006).
  Article CAS PubMed Google Scholar
• Chen, Y. C. et al. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 65, 11771–11778 (2005).
  Article CAS PubMed Google Scholar
• Zheng, S. L. et al. Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 64, 2918–2922 (2004).
  Article CAS PubMed Google Scholar
• Sun, J. et al. Sequence variants in Toll-like receptor gene cluster (TLR6–TLR1–TLR10) and prostate cancer risk. J. Natl Cancer Inst. 97, 525–532 (2005).
  Article CAS PubMed Google Scholar
• Chen, Y. C., Giovannucci, E., Kraft, P., Lazarus, R. & Hunter, D. J. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 16, 1982–1989 (2007).
  Article CAS PubMed Google Scholar
• Nieters, A., Beckmann, L., Deeg, E. & Becker, N. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor α and lymphoma risk. Genes Immun. 7, 615–624 (2006).
  Article CAS PubMed Google Scholar
• Forrest, M. S. et al. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br. J. Haematol. 134, 180–183 (2006).
  Article CAS PubMed Google Scholar
• Ohara, T., Morishita, T., Suzuki, H. & Hibi, T. Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of Toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas. Int. J. Mol. Med. 18, 59–63 (2006).
  CAS PubMed Google Scholar
• Boraska Jelavic, T. et al. Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin. Genet. 70, 156–160 (2006).
  Article CAS PubMed Google Scholar
• Song, C., Chen, L. Z., Zhang, R. H., Yu, X. J. & Zeng, Y. X. Functional variant in the 3′-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer Biol. Ther. 5, 1285–1291 (2006).
  Article CAS PubMed Google Scholar
• Hold, G. L. et al. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132, 905–912 (2007).
  Article CAS PubMed Google Scholar
• Tahara, T. et al. Toll-like receptor 2 – 196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci. 98, 1790–1794 (2007).
  Article CAS PubMed Google Scholar
• Cerhan, J. R. et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110, 4455–4463 (2007).
  Article CAS PubMed PubMed Central Google Scholar